DE LUCA, Giuseppe
 Distribuzione geografica
Continente #
EU - Europa 287
NA - Nord America 199
AS - Asia 116
OC - Oceania 2
Totale 604
Nazione #
US - Stati Uniti d'America 196
IT - Italia 154
SG - Singapore 79
IE - Irlanda 59
DE - Germania 28
IN - India 24
AT - Austria 14
FI - Finlandia 14
SE - Svezia 12
CN - Cina 5
CA - Canada 3
AU - Australia 2
HK - Hong Kong 2
IR - Iran 2
MY - Malesia 2
RU - Federazione Russa 2
TR - Turchia 2
FR - Francia 1
GB - Regno Unito 1
NL - Olanda 1
UA - Ucraina 1
Totale 604
Città #
Dublin 59
Singapore 45
Ashburn 40
Catania 38
Messina 32
Paternò 30
Boardman 21
Hyderabad 21
Frankfurt am Main 19
Turin 18
Vienna 14
Chandler 11
Milan 7
Helsinki 6
Lappeenranta 6
Los Angeles 6
New York 6
Washington 6
Nyköping 5
Santa Clara 5
Fiumefreddo di Sicilia 4
Riesi 4
Seattle 4
Beijing 3
Capri 3
Falls Church 3
Gunzenhausen 3
Jacksonville 3
Ankara 2
Carrara 2
Chateauguay 2
Gatchina 2
Isfahan 2
Kuala Lumpur 2
Mestre 2
Sydney 2
Acton 1
Ann Arbor 1
Bremen 1
Cambridge 1
Catanzaro 1
Des Moines 1
Forest City 1
Hong Kong 1
London 1
Medford 1
Miami 1
Montreal 1
Mountain View 1
Mumbai 1
Naaldwijk 1
Nashville 1
New Delhi 1
Nuremberg 1
Paris 1
Pliezhausen 1
Princeton 1
Rome 1
Sandston 1
Shanghai 1
Springfield 1
Tianjin 1
Wilmington 1
Woodbridge 1
Totale 466
Nome #
Analysis of beta 1 and beta 2-adrenergic receptors polymorphism in patients with apical ballooning cardiomyopathy 66
Immature platelet fraction and the extent of coronary artery disease: a single centre study 21
The Inconclusive Results of the Studies on Glycoprotein IIIa Platelet Receptor Gene Polymorphism and Coronary Artery Disease: An Area of Darkness 18
Acetylsalicylic acid desensitization in patients with coronary artery disease: A comprehensive overview of currently available protocols 17
Individualization of Duration of Dual Antiplatelet Therapy after Coronary Stenting: A Comprehensive, Evidence-Based Review 14
Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials 13
Absolute eosinophils count and the extent of coronary artery disease: a single centre cohort study 13
Mean platelet volume and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor 13
ANMCO/SICI-GISE paper on antiplatelet therapy in acute coronary syndrome 13
Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease 13
A meta-analytic overview of thrombectomy during primary angioplasty 12
Immature platelet fraction and the extent of coronary artery disease: A single centre study 12
Impact of diabetes on fibrinogen levels and its relationship with platelet reactivity and coronary artery disease: A single-centre study 12
Serum uric acid levels during dual antiplatelet therapy with ticagrelor or clopidogrel: Results from a single-centre study 11
Impact of Diabetes on Homocysteine Levels and Its Relationship with Coronary Artery Disease: A Single-Centre Cohort Study 11
Impact of diabetes on immature platelets fraction and its relationship with platelet reactivity in patients receiving dual antiplatelet therapy 10
Elevated Homocysteine and the Risk of Contrast-Induced Nephropathy: A Cohort Study 10
Neutrophil to Lymphocyte Ratio and the Extent of Coronary Artery Disease: Results from a Large Cohort Study 10
Comparison of Reduced-Dose Prasugrel and Standard-Dose Clopidogrel in Elderly Patients with Acute Coronary Syndromes Undergoing Early Percutaneous Revascularization 10
Glycosylated hemoglobin and the risk of periprocedural myocardial infarction in non-diabetic patients 10
Platelet HPA-1 a/HPA-1 b polymorphism and the risk of periprocedural myocardial infarction in patients undergoing elective PCI 10
Impact of time from symptom onset to drug administration on outcome in patients undergoing glycoprotein IIb-IIIa facilitated primary angioplasty (from the EGYPT Cooperation) 10
Platelet reactivity in patients with impaired renal function receiving dual antiplatelet therapy with clopidogrel or ticagrelor 10
Impact of age on long-term outcome after primary angioplasty with bare-metal or drug-eluting stent (from the DESERT cooperation) 9
Long-term results of the randomized comparison of everolimus-eluting stents and sirolimus-eluting stent in patients with ST elevation myocardial infarction (RACES-MI trial) 9
Comprehensive meta-analysis of radial vs femoral approach in primary angioplasty for STEMI 9
Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient- level meta-analysis of randomized trials 9
Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials 8
Impact of advanced age on myocardial perfusion, distal embolization, and mortality patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitors 8
Preinfarction angina does not affect infarct size in STEMI patients undergoing primary angioplasty 8
Switching from high-dose clopidogrel to prasugrel in ACS patients undergoing PCI: a single-center experience 8
Impact of hypertension on distal embolization, myocardial perfusion, and mortality in patients with ST segment elevation myocardial infarction undergoing primary angioplasty 8
Relationship between changes in platelet reactivity and ischemic events following percutaneous coronary intervention: a meta-regression analysis of 30 randomized trials 8
Meta-analysis of 14 trials comparing bypass grafting vs drug-eluting stents in diabetic patients with multivessel coronary artery disease 8
Bivalirudin Versus Unfractionated Heparin in Acute Coronary Syndromes: An Updated Meta-analysis of Randomized Trials 8
Mean platelet volume and the risk of periprocedural myocardial infarction in patients undergoing coronary angioplasty 8
Sirolimus-eluting versus paclitaxel-eluting stent in primary angioplasty: a pooled patient-level meta-analysis of randomized trials 8
Impact of diabetes on uric acid and its relationship with the extent of coronary artery disease and platelet aggregation: a single-centre cohort study 8
Benefits from intracoronary as compared to intravenous abciximab administration for STEMI patients undergoing primary angioplasty: a meta-analysis of 8 randomized trials 8
Platelet GP IIb-IIIa receptor antagonists in primary angioplasty: Back to the future 8
Impact of sex on uric acid levels and its relationship with the extent of coronary artery disease: A single-centre study 8
Meta-analysis comparing efficacy and safety of first generation drug-eluting stents to bare-metal stents in patients with diabetes mellitus undergoing primary percutaneous coronary intervention 8
Switching from Clopidogrel to Prasugrel in patients undergoing PCI: A meta-analytic overview 8
The role of statins in the prevention of contrast induced nephropathy: a meta-analysis of 8 randomized trials 7
Eosinophils count and periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions 7
Aging, impaired myocardial perfusion and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty 7
Uric acid and high-residual platelet reactivity in patients treated with clopidogrel or ticagrelor 7
Diabetes, glucose control and mean platelet volume: a single-centre cohort study 7
Impact of multivessel disease on infarct size among STEMI patients undergoing primary angioplasty 7
Aspirin desensitization in patients undergoing planned or urgent coronary stent implantation. A single-center experience 7
Gender-related differences in outcome after BMS or DES implantation in patients with ST-segment elevation myocardial infarction treated by primary angioplasty: insights from the DESERT cooperation 7
Benefits of statins in elderly subjects without established cardiovascular disease: a meta-analysis 7
Randomized comparison of everolimus-eluting stents and sirolimus-eluting stents in patients with ST elevation myocardial infarction: RACES-MI trial 7
Prevalence and predictors of high-on treatment platelet reactivity with ticagrelor in ACS patients undergoing stent implantation 7
Immature platelet fraction and high-on treatment platelet reactivity with ticagrelor in patients with acute coronary syndromes 7
Switching from clopidogrel to prasugrel in patients having coronary stent implantation 7
Vitamin D status, diabetes mellitus and coronary artery disease in patients undergoing coronary angiography 7
"Meta-Analysis of Ablation of Atrial Flutter and Supraventricular Tachycardia" 7
Platelet distribution width and the risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention 7
Time-related changes in neointimal tissue coverage of a novel Sirolimus eluting stent: Serial observations with optical coherence tomography 7
High-Density Lipoproteins and Coronary Artery Disease: A Single-Center Cohort Study 7
Impact of renal function on mean platelet volume and its relationship with coronary artery disease: A single-centre cohort study 6
Relationship Between Glycoprotein IIIa Platelet Receptor Gene Polymorphism and Coronary Artery Disease 6
Relationship between homocysteine and coronary artery disease. Results from a large prospective cohort study 6
Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials 6
Impact of hypertension on clinical outcome in STEMI patients undergoing primary angioplasty with BMS or DES: insights from the DESERT cooperation 6
Reduced antiplatelet therapy after drug-eluting stenting: Multicenter Janus Flex Carbostent implantation with short dual antiplatelet treatment - two or sIX months. MATRIX Study 6
Uric acid does not affect the prevalence and extent of coronary artery disease. Results from a prospective study 6
No-reflow reversibility: a study based on serial assessment of multiple biomarkers 6
Optimal Duration of Dual Antiplatelet Therapy After DES Implantation: A Meta-Analysis of 11 Randomized Trials 6
Pre-diabetes and the risk of contrast induced nephropathy in patients undergoing coronary angiography or percutaneous intervention 6
Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials 6
Impact of atorvastatin or rosuvastatin co-administration on platelet reactivity in patients treated with dual antiplatelet therapy 6
Advances in antithrombotic therapy as adjunct to reperfusion therapies for ST-segment elevation myocardial infarction 6
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor: Reply 6
Everolimus-eluting stent versus Sirolimus-eluting stent for prognostic significance 6
Adjunctive benefits from low-molecular-weight heparins as compared to unfractionated heparin among patients with ST-segment elevation myocardial infarction treated with thrombolysis. A meta-analysis of the randomized trials 6
Time-to-treatment and infarct size in STEMI patients undergoing primary angioplasty 6
Glycosylated hemoglobin and coronary artery disease in patients without diabetes mellitus 6
Drug-eluting stents in patients with anterior STEMI undergoing primary angioplasty: a substudy of the DESERT cooperation 6
Impact of gender difference on vitamin D status and its relationship with the extent of coronary artery disease 6
Impact of red blood cells count and high density lipoproteins with the prevalence and extent of coronary artery disease 6
Adjunctive mechanical devices to prevent distal embolization in patients undergoing mechanical revascularization for acute myocardial infarction: a meta-analysis of randomized trials 5
Adjunctive antithrombotic therapy during Primary PCI 5
Impact of diabetes on neutrophil-to-lymphocyte ratio and its relationship to coronary artery disease 5
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor 5
Clinical efficacy and safety of intracoronary vs. intravenous abciximab administration in STEMI patients undergoing primary percutaneous coronary intervention: A meta-analysis of randomized trials 5
Relation of Gender to Infarct Size in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Angioplasty 5
Evaluation of intracoronary adenosine to prevent periprocedural myonecrosis in elective percutaneous coronary intervention (from the PREVENT-ICARUS Trial) 5
Platelet glycoprotein IIIa Leu33Pro gene polymorphism and coronary artery disease: A meta-analysis of cohort studies 5
Smoking and infarct size among STEMI patients undergoing primary angioplasty 5
A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale 5
ORAl iMmunosuppressive therapy to prevent in-Stent rEstenosiS (RAMSES) cooperation: A patient-level meta-analysis of randomized trials 5
Impact of Diabetes on Long-Term Outcome After Primary Angioplasty: Insights from the DESERT cooperation 5
Facilitated PCI with combotherapy among STEMI patients. A meta-analysis of randomized trials 5
An unusual case of ECG ST-segment elevation 4
Antiplatelet Strategies for Older Patients with Acute Coronary Syndromes: Finding Directions in a Low-Evidence Field 4
Antithrombotic Therapy After Percutaneous Aortic Valve Implantation: Large Gaps for a Matter of Extreme Importance. Response 4
Aspiration thrombectomy and Primary PCI 4
Long-term outcome of drug-eluting stents compared with bare metal stents in st-segment elevation myocardial infarction results of the paclitaxel- or sirolimus-eluting stent versus bare metal stent in primary angioplasty (paseo) randomized trial (Retraction in: Circulation (2010) 121:8 (e228)) 3
Totale 839
Categoria #
all - tutte 9.373
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.373


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206 0 0 0 0 0 1 1 0 0 3 1 0
2020/20216 1 0 0 1 0 1 0 0 0 1 1 1
2021/202212 0 0 0 0 1 2 1 0 1 3 1 3
2022/2023709 2 3 1 4 4 5 3 4 11 474 198 0
2023/2024389 2 31 68 22 26 34 38 4 1 34 8 121
2024/202518 18 0 0 0 0 0 0 0 0 0 0 0
Totale 1.144